Synapse

← Matthias Egger

Papers by Matthias Egger

Page 11 · newest first

  1. Predictors of CD4+ T-Cell Counts of HIV Type 1–Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug ClassesThe Journal of Infectious Diseases · 2012
  2. Tuberculosis and the risk of opportunistic infections and cancers in HIV ‐infected patients starting ART in Southern AfricaTropical Medicine & International Health · 2012
  3. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapySexually Transmitted Infections · 2012
  4. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysisTropical Medicine & International Health · 2012
  5. Variability of Growth in Children Starting Antiretroviral Treatment in Southern AfricaPEDIATRICS · 2012
  6. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failureTropical Medicine & International Health · 2012
  7. Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort StudyPLoS Medicine · 2012
  8. Missed opportunities to prevent mother-to-child-transmissionAIDS · 2012
  9. Tenofovir in Second-Line ART in Zambia and South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes · 2012
  10. Completeness of Reporting in Randomized Controlled Trials of 3 VaccinesThe Pediatric Infectious Disease Journal · 2012
  11. Cancer, a disease of aging (part 1) – trends in older adult cancer mortality in Switzerland 1991–2008Swiss Medical Weekly · 2012
  12. Cancer, a disease of aging (part 2) – risk factors for older adult cancer mortality in Switzerland 1991–2008Swiss Medical Weekly · 2012
  13. Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinicTropical Medicine & International Health · 2012
  14. Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settingsBMC Infectious Diseases · 2012
  15. A Swiss neighbourhood index of socioeconomic position: development and association with mortalityJournal of Epidemiology & Community Health · 2012
  16. Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern AfricaInfectious Agents and Cancer · 2012
  17. Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy · 2012
  18. Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment OutcomesPLoS ONE · 2012
  19. Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes · 2012
  20. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern AfricaAIDS · 2012
  21. Distinguishing Case Series From Cohort StudiesAnnals of Internal Medicine · 2012
  22. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infectionBritish Journal of Cancer · 2012
  23. Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and SwitzerlandPLoS ONE · 2011
  24. All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaborationInternational Journal of Epidemiology · 2011
  25. Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV InfectionJournal of Clinical Microbiology · 2011
  26. Mortality and loss to follow-up in the first year of ARTAIDS · 2011
  27. Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South AfricaInfectious Agents and Cancer · 2011
  28. The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringAIDS · 2011
  29. Outcomes of Antiretroviral Treatment Programs in Rural Southern AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes · 2011
  30. STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE‐ME): An extension of the STROBE statementEuropean Journal of Clinical Investigation · 2011
  31. STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE StatementPLoS Medicine · 2011
  32. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statementMutagenesis · 2011
  33. STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statementJournal of Epidemiology & Community Health · 2011
  34. Association between Variants of the Leptin Receptor Gene (LEPR) and Overweight: A Systematic Review and an Analysis of the CoLaus StudySHILAP Revista de lepidopterología · 2011
  35. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trialsInternational Journal of Surgery · 2011
  36. “Pseudo-Beijing”: Evidence for Convergent Evolution in the Direct Repeat Region of Mycobacterium tuberculosisPLoS ONE · 2011
  37. Domains of physical activity and all-cause mortality: systematic review and dose–response meta-analysis of cohort studiesInternational Journal of Epidemiology · 2011
  38. Sensitization Prevalence, Antibody Cross-Reactivity and Immunogenic Peptide Profile of Api g 2, the Non-Specific Lipid Transfer Protein 1 of CeleryPLoS ONE · 2011
  39. Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – The IeDEA Southern Africa CollaborationTropical Medicine & International Health · 2011
  40. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesCochrane library · 2011
  41. Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and MortalityThe Journal of Clinical Endocrinology & Metabolism · 2011
  42. Childhood cancer and nuclear power plants in Switzerland: a census-based cohort studyInternational Journal of Epidemiology · 2011
  43. Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysisJournal of Viral Hepatitis · 2011
  44. Ageing with HIV: medication use and risk for potential drug-drug interactionsJournal of Antimicrobial Chemotherapy · 2011
  45. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern AfricaAIDS · 2011
  46. Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan AfricaInternational Journal of Epidemiology · 2011
  47. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couplesCochrane library · 2011
  48. Is Aboriginal Food Less Allergenic? Comparing IgE-Reactivity of Eggs from Modern and Ancient Chicken Breeds in a Cohort of Allergic ChildrenPLoS ONE · 2011
  49. Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsThe International Journal of Tuberculosis and Lung Disease · 2011
  50. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-FreseniusBlood · 2011